Meeting
2020 ASCO Virtual Scientific Program
Trial in progress: Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma.
Presenter
Joshua E. Reuss, MD
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Mesothelioma
Clinical Trial Registration Number
NCT03918252
Citation
J Clin Oncol 38: 2020 (suppl; abstr TPS9078)
DOI
10.1200/JCO.2020.38.15_suppl.TPS9078
Abstract #
TPS9078
Poster Bd #
271
Abstract Disclosures
Similar Videos & Slides
Speaker: Panel Discussion
Videos & Slides
2021 ASCO Annual Meeting
Choosing Wisely: Selecting the Right Population at the Right Time for DNA-Damaging Therapy
Speaker: Elizabeth M. Swisher, MD
Videos & Slides
2024 ASCO Breakthrough
Combination Therapy/Chemotherapy Immunotherapy and Emerging Neoadjuvant Therapy for Nasopharynx Cancer
Speaker: Anthony T. C. Chan, MD
Speaker: Jinsil Seong, MD, PhD